Background In the 5 years that have passed since the publication of the 2018 International
Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis …

The selection of pharmacotherapy for patients with allergic rhinitis aims to control the
disease and depends on many factors. Grading of Recommendations Assessment …

This comprehensive practice parameter for allergic rhinitis (AR) and nonallergic rhinitis
(NAR) provides updated guidance on diagnosis, assessment, selection of monotherapy and …

Allergic rhinitis (AR) is defined as a chronic, waxing/waning, immunoglobulin E (IgE)-based
inflammation in the nasopharynx that occurs in response to typically innocuous …

Influenza is a highly contagious, deadly virus, killing nearly half a million people yearly
worldwide. The classic symptoms of influenza are fever, fatigue, cough, and body aches. In …

Allergen immunotherapy (AIT) is a proven therapeutic option for the treatment of allergic
rhinitis and/or asthma. Many guidelines or national practice guidelines have been produced …

Health disparities are health differences linked with economic, social, and environmental
disadvantage. They adversely affect groups that have systematically experienced greater …

Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline by using the
best approach to integrated care pathways using mobile technology in patients with allergic …

Background The number of patients affected by allergies is increasing worldwide. The
resulting allergic diseases are leading to significant costs for health care and social systems …

Background Mobile health can be used to generate innovative insights into optimizing
treatment to improve allergic rhinitis (AR) control. Objectives A cross-sectional real-world …